Breakthroughs that break through pain and addiction
Channel Therapeutics is developing innovative non-addictive, drugs to treat
chronic neuropathic and acute and chronic eye pain.
See our Investor Presentation — Watch our interview at the Virtual Investor Conferences here.
“WE BELIEVE OUR LEAD COMPOUND WILL PROVIDE THE FOUNDATION FOR SIGNIFICANT ADVANCES IN NON-OPIOID TREATMENT OF ERYTHROMELALGIA, IDIOPATHIC SMALL FIBER NEURPATHY, EYE PAIN AND OTHER INDICATIONS.”